63 related articles for article (PubMed ID: 5454548)
41. Two new cases of hyperpyrimidinuria associated with excessive 5-fluorouracil toxicity.
Mans DR; Scaletzky A; Becker D; de Oliveria JR; Pinheiro CM; Bittar C; Ferreira Filho A; Machado VL; Ritt JL; Jung FA
Ann Oncol; 1994 Oct; 5(8):772-3. PubMed ID: 7826915
[No Abstract] [Full Text] [Related]
42. Hematologic adverse effects of aminoglutethimide.
Buzdar AU; Fraschini G; Blumenschein GR
Ann Intern Med; 1984 Jan; 100(1):159. PubMed ID: 6691645
[No Abstract] [Full Text] [Related]
43. 5-Fluorouracil (NSC-19893) in glucose and saline: therapeutic effect and toxicity.
Cressy NL; Schell HW
Cancer Chemother Rep; 1966 Dec; 50(9):683-4. PubMed ID: 5980747
[No Abstract] [Full Text] [Related]
44. [Rational use of chemotherapy in cancer and leukemia].
Mathé G
Therapeutique; 1970 Mar; 46(3):259-62. PubMed ID: 5422191
[No Abstract] [Full Text] [Related]
45. Letter: Dangers of petrol used as solvent.
Verwilghen RL; Van Dorpe A; Veulemans H
Lancet; 1975 Dec; 2(7945):1156. PubMed ID: 53649
[No Abstract] [Full Text] [Related]
46. Treatment-related leukopenia in anal cancer patients associated with worse outcome: results of a retrospective cohort study.
Nilsson MP; Scherman J; Gunnlaugsson A; Leon O; Johnsson A; Nilsson ED
Acta Oncol; 2020 Dec; 59(12):1508-1511. PubMed ID: 33074041
[No Abstract] [Full Text] [Related]
47. Excessive lacrimation from fluorouracil treatment.
Hamersley J; Luce JK; Florentz TR; Burkholder MM; Pepper JJ
JAMA; 1973 Aug; 225(7):747-8. PubMed ID: 4740487
[No Abstract] [Full Text] [Related]
48. 5-Fluorouracil: Friend or foe?
Kong F; Muir J
Aust J Gen Pract; 2021 Aug; 50(8):557-559. PubMed ID: 34333562
[No Abstract] [Full Text] [Related]
49. [Low-dose FP therapy for advanced and recurrent gastric cancer].
Yamashita Y; Ohira M; Sowa M; Shirasaka T; Hirakawa K; Chung YS
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1548-53. PubMed ID: 10553411
[TBL] [Abstract][Full Text] [Related]
50. [Changes in the hematopoietic system during treatment with 5-fluorouracil].
Voznyĭ EK
Vopr Onkol; 1970 Apr; 16(4):64-7. PubMed ID: 5454548
[No Abstract] [Full Text] [Related]
51. A clinical study of fluorouracil.
Nadler SH; Moore GE
Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
[No Abstract] [Full Text] [Related]
52. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients].
Chernyĭ VA
Vopr Onkol; 1970 Apr; 16(4):61-4. PubMed ID: 4989339
[No Abstract] [Full Text] [Related]
53. Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.
Innocenti F; Ratain MJ
Clin Cancer Res; 2002 May; 8(5):1314; author reply 1315-6. PubMed ID: 12006555
[No Abstract] [Full Text] [Related]
54. Experience with ftorafur treatment in breast cancer.
Karev NI; Blokhina NG; Vozny EK; Pershin MP
Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
[No Abstract] [Full Text] [Related]
55. Corticosteroids and fluorouracil toxicity.
Horton J; Olson KB; Hosley HF
Arch Intern Med; 1966 Jun; 117(6):775-7. PubMed ID: 5327216
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
